Goodwill And Intangible Assets

3 Months Ended

Jul. 31, 2013

Goodwill And Intangible Assets [Abstract]

4.Goodwill and Intangible Assets

The following tables present details of the Company’s goodwill and intangible assets as of July 31, 2013 and April 30, 2013 (in thousands).


		Gross				Net	Weighted-
		carrying		Accumulated		carrying	average
July 31, 2013		amount		amortization		amount	useful life
Indefinite Lives:
Goodwill	$	11,706	$	-	$	11,706	-
Finite Lives:
Customer-related		6,236		(3,893)		2,343	7 years
Technology-based		2,638		(1,800)		838	5 years
Trademarks		4,600		(1,014)		3,586	10 years
Trade name		100		(100)		-	2 years
Total	$	25,280	$	(6,807)	$	18,473

		Gross				Net	Weighted-
		carrying		Accumulated		carrying	average
April 30, 2013		amount		amortization		amount	useful life
Indefinite Lives:
Goodwill	$	11,706	$	-	$	11,706	-
Finite Lives:
Customer-related		6,236		(3,723)		2,513	7 years
Technology-based		2,638		(1,722)		916	5 years
Trademarks		4,600		(877)		3,723	10 years
Trade name		100		(100)		-	2 years
Total	$	25,280	$	(6,422)	$	18,858

Acquired finite-lived intangibles are generally amortized on a straight-line basis over their estimated useful lives. The useful life of finite-lived intangibles is the period over which the asset is expected to contribute directly or indirectly to future cash flows of the Company. Intangible assets amortization expense for the three months ended July 31, 2013 and 2012 was $0.4 million for each quarter. The estimated future amortization expense related to intangible assets as of July 31, 2013 is as follows (in thousands):


Fiscal Year Ending April 30,		Amount
Remainder of 2014	$	1,153
2015		1,512
2016		1,096
2017		814
2018		774
Thereafter		1,418
Total	$	6,767

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details